Michael Ward
Chief Executive Officer
BUSINESS
Aeterna Zentaris
Canada
Biography
Michael Ward working as Chief Executive Officer at Æterna Zentaris Aeterna Zentaris, Inc. 315 Sigma Drive, Suite 302D Charleston, SC 29486 (NASDAQ:SGNT), a global specialty generic pharmaceutical company, and led its sale to Nichi-Iko Pharmaceutical Co., Ltd. for $736 million. Mr. Ward has served as Strategic Advisor to Benevolent Capital Partners for the last five years and is currently a Partner with Outside GC LLC. Prior to Sagent Pharmaceuticals, Mr. Ward was Vice President, Assistant General Counsel of Global Compliance, Ethics & Litigation and Chief Privacy Officer at CDK Global. Mr. Ward has served in several executive roles and was responsible for business development, compliance, legal and operational matters in the healthcare, pharmaceutical and technology industries during his career. Mr. Ward graduated from Albion College and Case Western Reserve University Law School.
Research Interest
business development
